Thermo Fisher Scientific success story in Lithuania

Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.

Thermo Fisher Scientific came to Lithuania in 2010, when the company acquired a leading Lithuanian biotech company Fermentas for 260 million USD.

Now Thermo Fisher Scientific Vilnius site (Thermo Fisher Scientific Baltics, UAB) has world-class capabilities in manufacturing products for the life science market, specifically in molecular, protein, and cellular biology, and has an outstanding research and development (R&D) center, focused on the development of new products in all aspects of molecular, protein, and cellular biology. These products are broadly used worldwide to study gene structure, expression and variety, to create new diagnostics methods for innate, hereditary and infectious diseases.

Currently Vilnius site employs almost 1,900 people in a variety of roles making this one of the largest private R&D centers in whole region.